Laboratory Testing of CYP2D6 Alleles in Relation to Tamoxifen Therapy

Genetics in Medicine- United States

doi 10.1038/gim.2012.108

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment

Pharmaceuticals
Molecular MedicinePharmaceutical Science
2010English

CYP2D6 Genotype and Tamoxifen Activity: Understanding Interstudy Variability in Methodological Quality

Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Pharmacogenetics and Breast Cancer Endocrine Therapy: CYP2D6 as a Predictive Factor for Tamoxifen Metabolism and Drug Response?

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2008English

The Relationship Between the CYP2D6 Polymorphisms and Tamoxifen Efficacy in Adjuvant Endocrine Therapy of Breast Cancer Patients in Chinese Han Population

International Journal of Cancer
Cancer ResearchOncology
2018English

CYP2D6 Genotyping and Tamoxifen in the Treatment of Post-Menopausal Breast Cancer - A Reply

British Journal of Clinical Pharmacology
Pharmacology
2014English

Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen

Frontiers in Pharmacology
Pharmacology
2017English

Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

The Effect of CYP2B6, CYP2D6, and CYP3A4 Alleles on Methadone Binding: A Molecular Docking Study

Journal of Chemistry
Chemistry
2013English

List of Polymorphic Alleles Maintaining by Each Laboratory

Animal blood-group research information
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy